Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Argo Biopharma is a clinical-stage biotech company dedicated to developing a new generation of siRNA drugs to offer improved treatments for patients worldwide. Over the past two years, the company has established a diverse pipeline of siRNA drug candidates for various indications. Argo Biopharma utilizes its cutting-edge siRNA platform technology called RADS (RNA molecules with superior Activity, Durability, and Safety) in its...
Argo Biopharma is a clinical-stage biotech company dedicated to developing a new generation of siRNA drugs to offer improved treatments for patients worldwide. Over the past two years, the company has established a diverse pipeline of siRNA drug candidates for various indications. Argo Biopharma utilizes its cutting-edge siRNA platform technology called RADS (RNA molecules with superior Activity, Durability, and Safety) in its drug development efforts.

List your booth number for exhibitions, ask us